132 related articles for article (PubMed ID: 25826034)
21. Vascular disease in systemic sclerosis.
Poredos P
Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
[No Abstract] [Full Text] [Related]
22. [Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit
Takahashi S; Horie R; Yokoyama Y
Nihon Yakurigaku Zasshi; 2017; 149(1):49-58. PubMed ID: 28049880
[No Abstract] [Full Text] [Related]
23. Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water.
Cottin V
Eur Respir J; 2013 Apr; 41(4):781-3. PubMed ID: 23543646
[No Abstract] [Full Text] [Related]
24. Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
Nishibu A; Sakai E; Oyama N; Yamamoto T
Australas J Dermatol; 2012 May; 53(2):e32-3. PubMed ID: 22571581
[TBL] [Abstract][Full Text] [Related]
25. An update on sarcoidosis-associated pulmonary hypertension.
Bandyopadhyay D; Humbert M
Curr Opin Pulm Med; 2020 Sep; 26(5):582-590. PubMed ID: 32740377
[TBL] [Abstract][Full Text] [Related]
26. Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia.
Correale M; Tarantino N; Paradiso G; Monaco I; Di Biase M; Brunetti ND
Am J Ther; 2018; 25(5):e587-e590. PubMed ID: 29059078
[No Abstract] [Full Text] [Related]
27. Molecule of the month. Riociguat.
Drug News Perspect; 2009 Apr; 22(3):167. PubMed ID: 19440559
[No Abstract] [Full Text] [Related]
28. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
Sasahara AA
J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
[No Abstract] [Full Text] [Related]
29. [The PATENT-1 and CHEST-1 studies].
Casu G; Scelsi L; Morsolini M; D'Armini AM
G Ital Cardiol (Rome); 2015 Feb; 16(2):59-64. PubMed ID: 25805087
[No Abstract] [Full Text] [Related]
30. Riociguat (Adempas) for pulmonary hypertension.
Med Lett Drugs Ther; 2014 Mar; 56(1437):17-9. PubMed ID: 24589497
[No Abstract] [Full Text] [Related]
31. Pulmonary Hypertension in Parenchymal Lung Diseases: Any Future for New Therapies?
Harari S; Elia D; Humbert M
Chest; 2018 Jan; 153(1):217-223. PubMed ID: 28629920
[TBL] [Abstract][Full Text] [Related]
32. [Pulmonary hypertension].
Kovacs G; Olschewski H
Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
[No Abstract] [Full Text] [Related]
33. [New choice of therapy of pulmonary hypertension: endothelin receptor antagonist].
Shi GY
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):284-5. PubMed ID: 15854496
[No Abstract] [Full Text] [Related]
34. Pulmonary function test as screening test for pulmonary artery hypertension in scleroderma patients.
Gupta R
Rheumatology (Oxford); 2004 Oct; 43(10):1315; author reply 1316. PubMed ID: 15448223
[No Abstract] [Full Text] [Related]
35. Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts?
Pamidi S; Mehta S
J Rheumatol; 2009 Feb; 36(2):216-8. PubMed ID: 19208554
[No Abstract] [Full Text] [Related]
36. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Pulmonary Hypertension: Crosstalk between Respiration and Circulation].
Tatsumi K
Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1944-52. PubMed ID: 30160904
[No Abstract] [Full Text] [Related]
37. Pulmonary hypertension.
Tektonidou M
N Engl J Med; 2005 Jan; 352(4):418-9; author reply 418-9. PubMed ID: 15675104
[No Abstract] [Full Text] [Related]
38. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
Cannon JE; Pepke-Zaba J
Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
[TBL] [Abstract][Full Text] [Related]
39. Treatment of pulmonary hypertension: bench to bedside.
Springer J; Lainscak M; Salobir B; Lang IM
Respir Med; 2011 Oct; 105 Suppl 1():S7-11. PubMed ID: 22015091
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.
McLaughlin V; Humbert M; Coghlan G; Nash P; Steen V
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii25-31. PubMed ID: 19487219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
